MedLife, the market leader in healthcare services in Romania, has launched the Longevity 100+ genetic testing programme, the first and largest of its kind in the region. It will test at least 4,000 people across the country and be the basis for a research study on the genetic particularities of the working population, with the aim of supporting the development of personalised medicine and prevention policies. Mihai Marcu, CEO and Chairman of the Board of MedLife Group, took the time to talk to

Tag-uri: Medlife